Early Phase 1 Neoplasms Clinical Trials

9 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 19 of 9 trials

Recruiting
Early Phase 1

Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia

Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaMyeloproliferative Overlap Neoplasms+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins18 enrolled1 locationNCT07071155
Recruiting
Early Phase 1

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Non-Hodgkin LymphomaMultiple MyelomaErdheim-Chester Disease+1 more
Memorial Sloan Kettering Cancer Center30 enrolled1 locationNCT05093335
Recruiting
Early Phase 1

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

Urinary Bladder Neoplasms
Jodi Maranchie42 enrolled1 locationNCT04369560
Recruiting
Early Phase 1

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Multiple Myeloma and Malignant Plasma Cell Neoplasms
Peking University First Hospital50 enrolled2 locationsNCT06717113
Recruiting
Early Phase 1

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Pancreatic NeoplasmsOther Solid Tumors
Ruijin Hospital56 enrolled1 locationNCT06577532
Recruiting
Early Phase 1

Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors

Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences19 enrolled1 locationNCT06346041
Recruiting
Early Phase 1

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Lung Neoplasms
Peking Union Medical College Hospital60 enrolled1 locationNCT05543954
Recruiting
Early Phase 1

Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

Neoplasms
Instituto de Medicina Regenerativa100 enrolled1 locationNCT05475106
Recruiting
Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

Esophageal CancerHead and Neck CancerLaryngeal Cancer+4 more
Shanghai Yunying Medical Technology9 enrolled1 locationNCT05830240